Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07462767 · ClinicalTrials.gov registry record · Phase 1
Precision Microbiota Interventions for Senoreduction Trial
A Phase 1 study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Not yet
- Registry status
- Phase 1
- Development phase
- 160
- Enrollment target
NCT07462767 is a Phase 1 study that has not yet begun recruiting, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 160 participants.
The verdict
NCT07462767, a Phase 1 study, has not yet begun recruiting, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 160 participants
- Enrollment target
Study Summary
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Interventions
- DIETARY_SUPPLEMENT Limosilactobacillus reuteri
- DIETARY_SUPPLEMENT Blueberry extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2029-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07462767
The ClinicalTrials.gov registry entry for NCT07462767 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Limosilactobacillus reuteri is the first listed.
NCT07462767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07462767 about?
NCT07462767 is a clinical study titled "Precision Microbiota Interventions for Senoreduction Trial". People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
What is the current status of trial NCT07462767?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2026-04-01. Estimated completion is 2029-12-01.
What interventions are being tested in trial NCT07462767?
The interventions under investigation include: Limosilactobacillus reuteri (DIETARY_SUPPLEMENT), Blueberry extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07462767?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.